Decrease of dynamin 2 levels in late-onset Alzheimer's disease alters Aβ metabolism

被引:23
|
作者
Kamagata, Eiichiro [1 ]
Kudo, Takashi [1 ]
Kimura, Ryo [2 ]
Tanimukai, Hitoshi [1 ]
Morihara, Takashi [1 ]
Sadik, Md. Golam [1 ]
Kamino, Kouzin [3 ]
Takeda, Masatoshi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan
[2] Osaka Gen Med Ctr, Sumiyoshi Ku, Osaka 5588558, Japan
[3] Shoraiso Natl Hosp, Nara 6391042, Japan
关键词
Alzheimer's disease; Dynamin; Amyloid-beta peptide; Amyloid precursor protein; Lipid raft; AMYLOID PRECURSOR PROTEIN; MEDIATED ENDOCYTOSIS; EPITHELIAL-CELLS; GAMMA-SECRETASE; LIPID RAFTS; MEMBRANE; REGULATOR; GENE;
D O I
10.1016/j.bbrc.2008.12.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Late-onset Alzheimer's disease (LOAD) is significantly associated with a single nucleotide polymorphism located in the dynamin (DNM) 2 gene, especially in non-carriers of the apolipoprotein E-epsilon 4 allele. In this study we used real-time PCR to show that DNM2 mRNA is significantly reduced in the cortex of AD brains and in the peripheral blood of dementia patients. Neuroblastoma cells transfected with a dominant negative DNM2 had increased amyloid beta protein (A beta) secretion and most of the amyloid precursor protein (APP) in these cells was localized to the plasma membrane. In addition, these cells were rich in flotillin, which is a component of lipid rafts. These data Suggest that DNM2 expression is reduced in LOAD, which results in the accumulation of APP in lipid raft-rich plasma membranes. Consequently, A beta secretion may increase in LOAD neurons. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 695
页数:5
相关论文
共 50 条
  • [1] α2-macroglobulin in late-onset Alzheimer's disease
    Kovacs, DM
    EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 473 - 479
  • [2] Cannabinoids in Late-Onset Alzheimer's Disease
    Ahmed, A. I. A.
    van der Marck, M. A.
    van den Elsen, G. A. H.
    Rikkert, M. G. M. Olde
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (06) : 597 - 606
  • [3] The genetics of late-onset Alzheimer's disease
    Myers, AJ
    Goate, AM
    CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) : 433 - 440
  • [4] Type 2 Diabetes and Late-Onset Alzheimer's Disease
    Cheng, D.
    Noble, J.
    Tang, M. X.
    Schupf, N.
    Mayeux, R.
    Luchsinger, J. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (06) : 424 - 430
  • [5] Late-Onset Alzheimer Disease
    Pierce, Aimee L.
    Bullain, Szofia S.
    Kawas, Claudia H.
    NEUROLOGIC CLINICS, 2017, 35 (02) : 283 - +
  • [6] Late-onset autosomal dominant Alzheimer's disease
    Hancock, P.
    Larner, A. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 187 - 188
  • [7] CDC2 as a candidate for late-onset Alzheimer's disease
    Busby, VL
    Hamilton, G
    Walter, S
    Foy, C
    Archer, N
    Turic, D
    Jehu, L
    Hollingworth, P
    Moore, P
    Jones, S
    Jones, L
    Williams, J
    Owen, M
    Powell, J
    NEUROBIOLOGY OF AGING, 2004, 25 : S490 - S490
  • [8] Etiology and Pathogenesis of Late-Onset Alzheimer's Disease
    Balin, Brian J.
    Hudson, Alan P.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (03)
  • [9] LINKING Aβ AND TAU IN LATE-ONSET ALZHEIMER'S DISEASE
    Small, S. A.
    GERONTOLOGIST, 2009, 49 : 143 - 143
  • [10] Molecular genetics of late-onset Alzheimer's disease
    Kamboh, MI
    ANNALS OF HUMAN GENETICS, 2004, 68 : 381 - 404